Back icon Back
NewLimit

NewLimit

Company

NewLimit raises $130 million Series B led by Kleiner Perkins alongside NFDG, Khosla Ventures, Human Capital and others
NewLimit is developing medicines to extend human healthspan through epigenetic reprogramming
We founded NewLimit to develop medicines that add healthy years to each human life. Initially, we thought it would take many years to show progress

https://blog.newlimit.com/p/newlimit-raises-130-million-series

Date

May 6, 2025

Category

biotech

Lead investor

Country Icon Kleiner Perkins

Stage

Series B

Size

$130M

Explore similar Investments to NewLimit

Company
Size
Date
Lead Investor
Press
webAI

webAI

Company
$24M
Sep 10, 2024
Investor Sequoia
Source
Hadrian

Hadrian

Company
$260M
Jul 17, 2025
Investor Founders Fund
Source
Vercel

Vercel

Company
$250M
May 16, 2024
Investor Accel
Source
Reducto

Reducto

Company
$8.4M
Oct 2, 2024
Investor First Round Capital
Source
Particle

Particle

Company
$10.9M
Jun 11, 2024
Investor Lightspeed
Source
Tavus

Tavus

Company
$18M
Mar 12, 2024
Investor Scale Venture Partners
Source
Metronome

Metronome

Company
$50M
Feb 25, 2025
Investor NEA
Source
Cartesia

Cartesia

Company
$27M
Dec 12, 2024
Investor Index Ventures
Source
LiveKit

LiveKit

Company
$45M
Apr 10, 2025
Investor Altimeter Capital
Source
Mytra

Mytra

Company
$78M
Jul 23, 2024
Investor Eclipse
Source
Render

Render

Company
$80M
Jan 21, 2025
Investor Georgian
Source
Peec AI

Peec AI

Company
$8.2M
Jul 3, 2025
Investor 20VC
Source

Startups, venture funds
& everything in between.

Explore verified companies, top VCs, and practical guides built to help you raise, invest, and grow faster.
Made by Omnius. For builders, by builders.
Venture Funds Startups Investments Events Programs Case Studies Interviews & Lectures Reports & Publications